Technical Analysis for MRTX - Mirati Therapeutics, Inc.

Grade Last Price % Change Price Change
F 151.51 -2.48% -3.86
MRTX closed down 2.48 percent on Wednesday, May 5, 2021, on 1.51 times normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical MRTX trend table...

Date Alert Name Type % Chg
Earnings Movers Other 0.00%
Down 3 Days in a Row Weakness 0.00%
Fell Below 20 DMA Bearish -2.48%
Multiple of Ten Bearish Other -2.48%
Gapped Down Weakness -2.48%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -6.54%
20 DMA Support Bullish -8.85%
Up 3 Days in a Row Strength -8.85%
Slingshot Bearish Bearish Swing Setup -7.90%
Crossed Above 20 DMA Bullish -7.90%
Older End-of-Day Signals for MRTX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 3% about 9 hours ago
Fell Below Lower Bollinger Band about 9 hours ago
Down 2 % about 9 hours ago
60 Minute Opening Range Breakdown about 10 hours ago
Fell Below Previous Day's Low about 10 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Mirati Therapeutics Inc., a biopharmaceutical company, engages in the development of therapeutics for the cancer treatment. Its lead program in clinical development is MGCD265, a multi-targeted small molecule kinase inhibitor for treatment of oncology patients with solid tumors. The company also evaluates development opportunities in oncology for mocetinostat, a spectrum-selective HDAC inhibitor for the treatment of patients with myelodysplastic syndrome or lymphoma; and MGCD516, a kinase inhibitor with a target profile for the treatment of patients with non-small cell lung cancer and other solid tumors. Mirati Therapeutics Inc. is headquartered in San Diego, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Clinical Development Solid Tumors Oncology Chemical Compounds Lymphoma Small Cell Lung Cancer Non Small Cell Lung Cancer Cancer Treatment Targeted Therapy Myelodysplastic Syndrome Bemcentinib

Is MRTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 249.42
52 Week Low 91.9
Average Volume 412,940
200-Day Moving Average 185.12
50-Day Moving Average 174.30
20-Day Moving Average 160.12
10-Day Moving Average 158.99
Average True Range 7.79
ADX 28.09
+DI 15.28
-DI 28.27
Chandelier Exit (Long, 3 ATRs ) 154.70
Chandelier Exit (Short, 3 ATRs ) 173.64
Upper Bollinger Band 169.57
Lower Bollinger Band 150.67
Percent B (%b) 0.04
BandWidth 11.80
MACD Line -4.66
MACD Signal Line -5.21
MACD Histogram 0.5523
Fundamentals Value
Market Cap 7.48 Billion
Num Shares 49.4 Million
EPS -4.19
Price-to-Earnings (P/E) Ratio -36.20
Price-to-Sales 809.26
Price-to-Book 21.13
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 163.26
Resistance 3 (R3) 164.30 161.41 161.30
Resistance 2 (R2) 161.41 158.42 160.90 160.65
Resistance 1 (R1) 156.46 156.57 155.02 155.43 160.00
Pivot Point 153.58 153.58 152.86 153.06 153.58
Support 1 (S1) 148.63 150.59 147.19 147.59 143.02
Support 2 (S2) 145.74 148.74 145.23 142.37
Support 3 (S3) 140.79 145.74 141.72
Support 4 (S4) 139.76